Durham Mark Andrew 4
4 · Valeant Pharmaceuticals International, Inc. · Filed May 13, 2011
Insider Transaction Report
Form 4
Durham Mark Andrew
SVP, Human Resources
Transactions
- Exercise/Conversion
Common Stock, no par value
2011-05-11$24.50/sh+50,000$1,225,000→ 111,595 total - Sale
Common Stock, no par value
2011-05-11$52.17/sh−50,000$2,608,500→ 61,595 total - Exercise/Conversion
Stock Options (right to purchase)
2011-05-11−50,000→ 0 totalExercise: $24.50From: 2009-03-01Exp: 2011-05-25→ Common Stock, no par value (50,000 underlying)
Footnotes (1)
- [F1]The reporting person is exercising stock options that were set to expire on May 25, 2011 if unexercised.